| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Okt―24 |
SARS-CoV-2 Spike displays multiple adaptive changes in addition to the furin cleavage site. |
Robert F. Garry |
| 2 |
[GO] |
2025―Sep―11 |
Generation and application of novel DNA aptamers targeted to the nucleocapsid protein of the SARS-CoV-2 |
Xinyue Zhang, Lingfeng Guan, Hanchuan Wang, Jiaxin Liu, Xinyan Wei, Zhenghong Xu, Shaowen Wang, Qiwei Qin |
| 3 |
[GO] |
2025―Sep―01 |
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant |
Lu Zhang, Amy Kempf, Inga Nehlmeier, Nianzhen Chen, Luise Graichen, Anna-Sophie Moldenhauer, Metodi V. Stankov, Christine Happle, Sebastian R. Schulz, Alexandra Dopfer-Jablonka, Hans-Martin Jäck, Georg.M.N. Behrens, Stefan Pöhlmann, Markus Hoffmann |
| 4 |
[GO] |
2025―Aug―23 |
Assessment of γ-herpesvirus infection dynamics in non-hospitalised people living with HIV during the COVID-19 pandemic in South Africa |
Prishanta Chinna, Melissa J. Blumenthal, Humaira Lambarey, Lauren Jennings, Catherine Orrell, Georgia Schäfer |
| 5 |
[GO] |
2025―Aug―21 |
Synergistic Antiviral Activity of a Cathepsin B/L Inhibitor and a TMPRSS2 Inhibitor against SARS-CoV-2 in vitro and in vivo |
Shinsuke Toba, Kentaro Uemura, Takao Sanaki, Shinji Kusakabe, Kei Konishi, Shigeru Miki, Yuki Maruyama, Atsuhiro Iimuro, Takao Shishido, Michihito Sasaki, Yasuko Orba, William W. Hall, Hirofumi Sawa, Akihiko Sato |
| 6 |
[GO] |
2025―Aug―20 |
Zebrafish as a model for SARS-CoV-2 infection, pathogenesis, transmission, and drug screening |
Chinnarajan Ravindran, Srestha Mukherjee |
| 7 |
[GO] |
2025―Aug―18 |
A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity |
Lucini Paioni Alessandro, Donnici Lorena, Nodari Riccardo, Longo Minnolo Marika, Ferraro Anastasia, Alberico Alessia, Brindisi Margherita, Mejías-Pérez Ernesto, Keppler Oliver T, Summa Vincenzo, Guidotti Luca G, Albanese Manuel, De Francesco Raffaele |
| 8 |
[GO] |
2025―Jul―21 |
Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants |
Mariângela de Oliveira Silva, Isabela Pazotti Daher, Catarina Harumi Oda Ibrahim, Edmarcia Elisa de Souza, Edilberto Postol, Raquel Elaine de Alencar, Guilherme Antônio de Souza Silva, Rodolfo Ferreira Marques, Flávia Lopes Adami, Viviane Schuch, Marcio Massao Yamamoto, Bianca da Silva Almeida, Gabriela Koike, Isabela Resende Azevedo, Maria Fernanda Castro-Amarante, Daniela Santoro Rosa, Edison Luiz Durigon, Carsten Wrenger, Edecio Cunha-Neto, Jorge Kalil, Silvia Beatriz Boscardin |
| 9 |
[GO] |
2025―Jul―15 |
Impact of the COVID-19 pandemic on the molecular epidemiology of respiratory rhinoviruses and enteroviruses in Tunisia |
Fahmi Smaoui, Awatef Taktak, Saba Gargouri, Amel Chtourou, Rim Kharrat, Ahmed Rebai, Lamia Feki-Berrajah, Hela Karray-Hakim |
| 10 |
[GO] |
2025―Jul―02 |
Corrigendum to: An early ‘classical’ swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice [Virology, volume 393/2 (2009) 539, 338 - 345 |
Matthew J. Memoli, Terrence M. Tumpey, Brett W. Jagger, Vivien G. Dugan, Zong-Mei Sheng, Li Qi, John C. Kash, Jeffery K. Taubenberger |
| 11 |
[GO] |
2025―Jun―20 |
Safety of SARS-CoV-2 XBB.1.5 and seasonal influenza vaccines co-administration: data from a perspective observational active surveillance study. Puglia (Italy), season 2023/2024 |
Stefanizzi Pasquale, Lorenza Moscara, Claudia Palmieri, Andrea Martinelli, Silvia Fontanelli, Cristina Bellomo, Giuseppe Spinelli, Tafuri Silvio |
| 12 |
[GO] |
2025―Jun―20 |
The Spike 486 site is a key immune evasion point and a determinant of the immunogenicity of the RBD-Dimer mRNA vaccine against SARS-CoV-2 variants |
Simin Feng, Mengting Huang, Yun Quan, Lei Sun, Jinzhong Lin, Danyang Zhang, Xuepeng Wei, Zhongfang Wang, Xiancai Ma, Shaobo Wang, Qianyu Pan, Weixin Jia, Dandan Wei, Guangxue Feng, Menghan Xu, Zengqin Deng, Qiong Zhang |
| 13 |
[GO] |
2025―Jun―12 |
SARS-CoV-2 host-pathogen interactome: insights into more players during pathogenesis |
S. Mothae, T.E. Chiliza, N.E. Mvubu |
| 14 |
[GO] |
2025―Jun―06 |
Synergistic interference with SARS-CoV-2 replication by molnupiravir-derived N4-hydroxycytidine and inhibitors of CTP synthetase in cell culture |
Kim M. Stegmann, Antje Dickmanns, Hannah L. Fuchs, David Scheibner, Björn-Patrick Mohl, Florian R. Moeselaken, Wencke Reineking, Theresa Störk, Asisa Volz, Philip A. Beer, Andrew E. Parker, Veronika Pilchova, Christian Meyer zu Natrup, Maren von Köckritz-Blickwede, Wolfgang Baumgärtner, Anne Balkema-Buschmann, Matthias Dobbelstein |
| 15 |
[GO] |
2025―Mai―28 |
Intestinal Organoids: A Novel and Ideal in vitro Platform for Swine Enteric Coronavirus Investigations |
Yue Zhang, Ning Yang, Qing Li, Yutong Tang, Bingrong Bai, Guangliang Liu |
| 16 |
[GO] |
2025―Mai―26 |
Drivers of quasispecies development in SARS-CoV-2 and implications for emergent variants and COVID-19 |
Mathias Smet, Matilda Berkell, Anna Górska, Evelina Tacconelli, Samir Kumar-Singh, Surbhi Malhotra-Kumar |
| 17 |
[GO] |
2025―Mai―25 |
First linear B-cell epitope identified on the nucleocapsid protein of bovine coronavirus |
Yulong Zhou, Jiawen Zhang, Hailiang Wu, Shuai Zhao, Yachao Ren, Qiuhui Chen, Zhe Zhang, Xianmao Liao, Yuming Mo, Yiming Zhong, Guohua Zhang |
| 18 |
[GO] |
2025―Mai―22 |
Multi-level Inhibition of SARS-CoV-2 Invasion by Cannabidiol and Epigallocatechin Gallate |
Meng-Chun Zhang, Hao Wu, Jiaxing Wang, Meixi Lu, Danli Cao, Jingwen Lin, Hang Chen, Caiji Lin, Yao Wang, Xing-Hua Zhang, Mengzhi Xu, Gui-Rong Liu, Han Li, Pengfei Wang, Xiaoyu Wang, Xiaohui Xu, Shu-Lin Liu, Huidi Liu |
| 19 |
[GO] |
2025―Mai―19 |
Porcine Respiratory Coronavirus in 10 Provinces of China : Molecular Epidemiology, Genetic Diversity, and Pathogenesis of the Isolated PRCV/NM Strain |
Shihao Ding, Jie Ni, Xiaodong Liu, Dongliang Li, Jingliang Su, Farong Xu, Pinghuang Liu |
| 20 |
[GO] |
2025―Mai―14 |
Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis |
Stine Sofie Frank Lende, Frederik Holm Rothemejer, Malthe Andreas, Maria Lange Pedersen, Laura Traberg-Nyborg, Emma Falling Iversen, Anna Karina Juhl, Ole Schmeltz Søgaard, Mariane Høgsbjerg Schleimann, Martin Tolstrup |
| 21 |
[GO] |
2025―Apr―25 |
Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium |
Dorothee Reuss, Jonathan C. Brown, Ksenia Sukhova, Wilhelm Furnon, Vanessa Cowton, Arvind H. Patel, Massimo Palmarini, Catherine Thompson, Wendy S. Barclay |
| 22 |
[GO] |
2025―Apr―12 |
A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main protease activity |
Le Cao, Shuyuan Shi, Chaofeng Zhang, Cheng Zhao |
| 23 |
[GO] |
2025―Apr―09 |
Genetic diversity of canine coronavirus identified in dogs in Yulin city, southern China |
Chun-Yang Lian, Xin-Yan Yao, Zhi-Hang Lv, Xue-Lian Zhang, Jian-Wei Shao |
| 24 |
[GO] |
2025―Mrz―22 |
Translational research on pandemic virus infection using nonhuman primate models |
Hirohito Ishigaki, Yasushi Itoh |
| 25 |
[GO] |
2025―Mrz―22 |
Defining diverse Spike-Receptor interactions involved in SARS-CoV-2 entry: Mechanisms and Therapeutic Opportunities |
Michael Anderson, Julian Lopez, Maya Wyr, Peter W. Ramirez |
| 26 |
[GO] |
2025―Mrz―22 |
Multiple Exposures to SARS-CoV-2 Spike enhance Cross-Reactive Antibody-Dependent Cellular Cytotoxicity against SARS-CoV-1 |
Guillaume Beaudoin-Bussières, Alexandra Tauzin, Katrina Dionne, Omar El Ferri, Mehdi Benlarbi, Catherine Bourassa, Halima Medjahed, Renée Bazin, Marceline Côté, Andrés Finzi |
| 27 |
[GO] |
2025―Mrz―21 |
Recent SARS-CoV-2 evolution trajectories indicate the emergence of Omicron’s several subvariants and the current rise of KP.3.1.1 and XEC |
Chiranjib Chakraborty, Manojit Bhattacharya, Ali Saber Abdelhameed |
| 28 |
[GO] |
2025―Mrz―20 |
A Meta-Analysis on the Immunogenicity of Prototype, Monovalent-adapted and Bivalent vaccines against SARS-CoV-2 Wildtype, Omicron BA.1 and Omicron BA.4/5 in Healthy Adults. |
Jo-Lewis Banga Ndzouboukou, Abdul A. Kamara, Nadeem Ullah, Qing Lei, Xiong-lin Fan |
| 29 |
[GO] |
2025―Mrz―07 |
SARS-CoV-2 Nsp13 Helicase Modulates miR-146a-Mediated Signaling Pathways |
Eryn Lundrigan, Spencer Uguccioni, Christine Hum, Nadine Ahmed, John Paul Pezacki |
| 30 |
[GO] |
2025―Feb―25 |
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon |
Mehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, Maxime Côté-Chenette, Guillaume Beaudoin-Bussières, Étienne Bélanger, Shilei Ding, Oumarou H. Goni, Yannick F. Ngoume, Alexandra Tauzin, Halima Medjahed, Elodie Ghedin, Ralf Duerr, Andrés Finzi, Marcel Tongo |
| 31 |
[GO] |
2025―Feb―21 |
Emergence, prevalence and evolution of porcine reproductive and respiratory syndrome virus 1 in China from 1994 to 2024 |
Yuejia Qiu, Ming Qiu, Shubin Li, Shubo Li, Jianzhong Zhu, Kegong Tian, Nanhua Chen |
| 32 |
[GO] |
2025―Feb―03 |
Intraspecific SARS-CoV-2 Delta Variant Transmission among Red Fox (Vulpes vulpes) and Striped Skunk (Mephitis mephitis) |
Stephanie M. Porter, Airn E. Hartwig, Marissa Quilici, Angela M. Bosco-Lauth, J. Jeffrey Root |
| 33 |
[GO] |
2025―Feb―01 |
Porcine epidemic diarrhea coronavirus infection activates caspase-8 to enhance innate immunity by blocking CYLD-mediated deubiquitination of RIG-I |
Huidi Yu, Linshan He, Xuemei Wu, Miao Zhang, Zhenhai Chen, Jing Sun, Xiulong Xu |
| 34 |
[GO] |
2025―Jan―27 |
Bats as a mixing vessel for generation of novel coronaviruses: Co-circulation and co-infection of coronaviruses and other viruses |
Antonio.C.P. Wong, Susanna.K.P. Lau, Patrick.C.Y. Woo |
| 35 |
[GO] |
2025―Jan―19 |
Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies |
Mario Fragoso-Saavedra, Qiang Liu |
| 36 |
[GO] |
2025―Jan―18 |
Current trends and future potential in the detection of avian coronaviruses: An emphasis on sensors-based technologies. |
Md. Safiul Alam Bhuiyan, Suman Das Gupta, Juplikely James Silip, Saranika Talukder, Md. Hakimul Haque, Jade K. Forwood, Subir Sarker |
| 37 |
[GO] |
2025―Jan―17 |
Structural Insights into Nucleocapsid Protein Variability: Implications for PJ34 Efficacy Against SARS-CoV-2 |
Akima Yamamoto, Haruki Ito, Takemasa Sakaguchi, Akifumi Higashiura |
| 38 |
[GO] |
2025―Jan―11 |
Antibody responses in Omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2 |
Yabo Zhao, Weili Li, Liming Xu, Zhanling Tao, Junhe Zhang |
| 39 |
[GO] |
2025―Jan―11 |
Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction |
Ankita Saha, Shweta Choudhary, Priyanshu Walia, Pravindra Kumar, Shailly Tomar |
| 40 |
[GO] |
2025―Jan―10 |
Bat coronavirus surveillance across different habitats in Yucatán, México |
Marco Antonio Jiménez Rico, Ana Laura Vigueras-Galván, Erika Nayelli Hernández Villegas, Paola Martínez Duque, David Roiz, Luisa I. Falcón, Ella Vázquez-Domínguez, Osiris Gaona, Audrey Arnal, Benjamin Roche, Rosa Elena Sarmiento Silva, Gerardo Suzán |
| 41 |
[GO] |
2025―Jan―07 |
Antiviral Mechanism of Fuzhengjiedu San against Porcine Reproductive and Respiratory Syndrome Virus |
Xin-Qi Song, Xin-Yi Zhao, Wen-Shuang Chen, Li Yang, Dong-Yu Liu, Ya-Ping Chen |
| 42 |
[GO] |
2025―Jan―06 |
Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins |
Francesca R. Hills, Jemma L. Geoghegan, Mihnea Bostina |
| 43 |
[GO] |
2024―Dez―25 |
Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants |
Berenice Calderón-Pérez, Leandro Alberto Núñez-Muñoz, Lady Laura Trejo-Ayala, Víctor Hugo Rosales-García, Benjamín Emmanuel Chávez-Álvarez, Brenda Yazmín Vargas-Hernández, José Abrahán Ramírez-Pool, Roberto Ruiz-Medrano, Beatriz Xoconostle-Cázares |
| 44 |
[GO] |
2024―Dez―22 |
Intra-host variability of SARS-CoV-2: Patterns, causes and impact on COVID-19 |
Leandro R. Jones |
| 45 |
[GO] |
2024―Dez―21 |
Host microRNAs as Regulators of Porcine Reproductive and Respiratory Syndrome Virus Infection |
Shu-yuan Guo, Wen-hai Feng |
| 46 |
[GO] |
2024―Dez―05 |
Exploring the role of carbon quantum dots as countermeasure for SARS-CoV-2 virus |
Kallol Roy, Binoy K. Saikia, Rituraj Konwar |
| 47 |
[GO] |
2024―Nov―29 |
The novel COVID-19 treatment VV116 is a potential inhibitor of Zika virus |
Shaokang Yang, Xiaotong Yang, Weiyan Zhu, Chongda Luo, Xintong Yan, Wei Li, Ruiyuan Cao, Wu Zhong |
| 48 |
[GO] |
2024―Nov―29 |
Isolation and molecular characterization of an enteric isolate of the Genotype-Ia Bovine coronavirus with notable mutations in the receptor binding domain of the spike glycoprotein. |
Abid Shah, Phillip Gauger, Maged Gomaa Hemida |
| 49 |
[GO] |
2024―Nov―21 |
Research progress on the molecular mechanism of immune escape of porcine reproductive and respiratory syndrome virus |
Wenwen Hu, Deyuan Tang, Zhiyong Zeng, Bin Wang, Min Zhou, Yinming Mao, Piao Zhou, Song He |
| 50 |
[GO] |
2024―Nov―05 |
Strengths and limitations of SARS-CoV-2 virus-like particle systems |
Rokaia Sultana, Robert V. Stahelin |
| 51 |
[GO] |
2024―Nov―04 |
Genomic RNA Recombination of Porcine Reproductive and Respiratory Syndrome Virus and Other Arteriviruses |
Junyu Tang, Yu Fan Hung, Dongwan Yoo |
| 52 |
[GO] |
2024―Okt―18 |
The Ex Vivo Infection of the Peripheral Bovine Mononuclear Cells (PBMCs) and the Bovine Spleen Cells with the Bovine Coronavirus (BCoV) Induced a Differential Expression of the Host Cytokine Genes Profiles and Modulates the Virus Replication |
Abid Ullah Shah, Maged Gomaa Hemida |
| 53 |
[GO] |
2024―Okt―01 |
Biochemical simulation of mutation synthesis and repair during SARS-CoV-2 RNA polymerization |
Adrian Oo, Zhenhang Chen, Dongdong Cao, Young-Jae Cho, Bo Liang, Raymond F. Schinazi, Baek Kim |
| 54 |
[GO] |
2024―Sep―10 |
Receptor binding mechanism and immune evasion capacity of SARS-CoV-2 BQ.1.1 lineage |
Chenghai Wang, Yu Zhang, Chen Yang, Wenlin Ren, Chenguang Qiu, Shilong Fan, Qiang Ding, Jun Lan |
| 55 |
[GO] |
2024―Sep―08 |
Control of nuclear localization of the nucleocapsid protein of SARS-CoV-2 |
Mengrui Wang, Maria Valadez-Ingersoll, Thomas D. Gilmore |
| 56 |
[GO] |
2024―Jul―23 |
Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi Complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit. |
Yanjun Wu, Soak Kuan Lai, Conrad En-Zuo Chan, Boon Huan Tan, Richard J. Sugrue |
| 57 |
[GO] |
2024―Jul―03 |
The emergence, isolation, and phylogenetic analysis of a closely related human strain of parainfluenza virus 5 from a case of porcine reproductive and respiratory syndrome in China |
Jiaqi Liu, Tongwei Ren, Xindong Wang, Hao Wang, Guochang Chen, Yifeng Qin, Kang Ouyang, Ying Chen, Weijian Huang, Zuzhang Wei |
| 58 |
[GO] |
2024―Jul―02 |
Inactivation efficacy and mechanism of 9.375 GHz electromagnetic wave on coronavirus |
Yi Xiao, Hui Wang, Haoyu Wang, Ji Dong, Ruiyun Peng, Li Zhao |
| 59 |
[GO] |
2024―Jun―19 |
Peptide S4 is an entry inhibitor of SARS-CoV-2 infection |
Zhiyu Liang, Jiamei Wang, Huan Zhang, Lixia Gao, Jun Xu, Peiran Li, Jie Yang, Xinting Fu, Han Duan, Jiayan Liu, Tiancai Liu, Weifeng Ma, Kun Wu |
| 60 |
[GO] |
2024―Mai―23 |
Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes |
Piotr Rzymski, Jacek Niedziela, Barbara Poniedziałek, Joanna Rosińska, Dorota Zarębska-Michaluk, Barbara Sobala-Szczygieł, Robert Flisiak, Mariusz Gąsior, Jerzy Jaroszewicz |
| 61 |
[GO] |
2024―Mai―10 |
Identification of B-cell epitope on the N protein of Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) using Monoclonal Antibody and Construction of Epitope-mutated Virus |
Jiaqi Liu, Xindong Wang, Tongwei Ren, Jianguang Qin, Yifeng Qin, Kang Ouyang, Ying Chen, Weijian Huang, Zuzhang Wei |
| 62 |
[GO] |
2024―Apr―26 |
Porcine reproductive and respiratory syndrome virus nsp4-mediated β2M downregulation contributes to SLA-I decrease and virus infection in vivo and in vitro |
Lei Kang, Abdul Wahaab, Pengfei Qi, Yafeng Qiu, Jianchao Wei, Beibei Li, Donghua Shao, Zongjie Li, Ke Liu, Zhiyong Ma, Shuo Su |
| 63 |
[GO] |
2024―Apr―08 |
Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication |
Shiori Ueno, Sodbayasgalan Amarbayasgalan, Yoshiro Sugiura, Tatsuki Takahashi, Kenta Shimizu, Keisuke Nakagawa, Reika Kawabata-Iwakawa, Wataru Kamitani |
| 64 |
[GO] |
2024―Apr―02 |
Porcine respiratory coronavirus genome sequences; comparisons and relationships to transmissible gastroenteritis viruses |
Amalie Ehlers Bedsted, Thomas Bruun Rasmussen, Laura D. Martinenghi, Anette Bøtner, Hans Nauwynck, Graham J. Belsham |
| 65 |
[GO] |
2024―Mrz―14 |
Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaque |
Cong Thanh Nguyen, Misako Nakayama, Hirohito Ishigaki, Yoshinori Kitagawa, Akemi Kakino, Marumi Ohno, Masashi Shingai, Yasuhiko Suzuki, Tatsuya Sawamura, Hiroshi Kida, Yasushi Itoh |
| 66 |
[GO] |
2024―Mrz―08 |
The investigation of the dynamics of changes in neutralizing antibody titers against type 5 adenovirus in the context of vaccination against a new coronavirus infection |
I.V. Amosova, T.A. Timoshicheva, R.A. Kadyrova, Y.A. Zabrodskaya, V.S. Vakin, M.P. Grudinin, V.V. Dzytseva, M.S. Khmelevsky, D.A. Lioznov |
| 67 |
[GO] |
2024―Mrz―07 |
Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity |
Xiaotong Zheng, Rong Yang, Yuxiu Zhao, Yadan Zhang, Guangying Yuan, Weidong Li, Zhuangzhuang Xiao, Xiaofei Dong, Meng Ma, Yancen Guo, Wei Wang, Xue Zhao, Hongqiang Yang, Shaoting Qiu, Zheng Peng, Ankang Liu, Shouzhi Yu, Yuntao Zhang |
| 68 |
[GO] |
2024―Feb―27 |
Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus |
Binoy K. Saikia, Kallol Roy, Rituraj Konwar |
| 69 |
[GO] |
2024―Jan―28 |
A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice. |
Fabrizia Valleriani, Chiara Di Pancrazio, Massimo Spedicato, Giovanni Di Teodoro, Daniela Malatesta, Tetyana Petrova, Francesca Profeta, Maria Loredana Colaianni, Shadia Berjaoui, Ilaria Puglia, Marialuigia Caporale, Emanuela Rossi, Maurilia Marcacci, Mirella Luciani, Flavio Sacchini, Ottavio Portanti, Francesco Bencivenga, Nicola Decaro, Francesco Bonfante, Alessio Lorusso |
| 70 |
[GO] |
2024―Jan―06 |
The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells |
Noelia H. Altina, David G. Maranon, John R. Anderson, Meghan K. Donaldson, Suad Elmegerhi, Laura A. St Clair, Rushika Perera, Brian J. Geiss, Jeffrey Wilusz |
| 71 |
[GO] |
2023―Nov―28 |
Avian coronavirus infectious bronchitis virus Beaudette strain NSP9 interacts with STAT1 and inhibits its phosphorylation to facilitate viral replication |
Ting Xia, Shengkui Xu, Xueyan Li, Wenke Ruan |
| 72 |
[GO] |
2023―Nov―28 |
Three distinct ORF1a recombinants of the SARS-CoV-2 Delta variant of concern |
Dong-Wook Lee, Jeong-Min Kim, Da-Won Kim, Ji-Yun Kim, Jeong-Ah Kim, Chae Young Lee, Jin Sun No, Il-Hwan Kim, Jee Eun Rhee, Eun-Jin Kim, Jung-Hoon Kwon |
| 73 |
[GO] |
2023―Nov―14 |
A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein |
Yuting Zhang, Dan Wang, Qi Xiang, Xiaohui Hu, Yuting Zhang, Lijie Wu, Zhaoyong Zhang, Yanqun Wang, Jincun Zhao, Peter J. McCormick, Jinheng Fu, Yang Fu, Jin Zhang, Haihai Jiang, Jian Li |
| 74 |
[GO] |
2023―Nov―07 |
Reassortant H9N2 canine influenza viruses containing the pandemic H1N1/2009 ribonucleoprotein complex circulating in pigs acquired enhanced virulence in mice |
Min Zhu, Hao Zeng, Jianqiao He, Yaohui Zhu, Pingping Wang, Jianing Guo, Jinfan Guo, Huabo Zhou, Yifeng Qin, Kang Ouyang, Zuzhang Wei, Weijian Huang, Ying Chen |
| 75 |
[GO] |
2023―Nov―02 |
Identification of subgenomic mRNAs derived from the coronavirus 1a/1b protein gene: Implications for coronavirus transcription |
Ching-Hung Lin, Feng-Cheng Hsieh, Meilin Wang, Chieh Hsu, Hsuan-Wei Hsu, Chun-Chun Yang, Cheng-Yao Yang, Hung-Yi Wu |
| 76 |
[GO] |
2023―Okt―31 |
Broad spectrum post-entry inhibitors of coronavirus replication: Cardiotonic steroids and monensin |
Shahrzad Jahanshahi, Hong Ouyang, Choudhary Ahmed, Ali Zahedi Amiri, Subha Dahal, Yu-Qian Mao, David A.J. Van Ommen, Ramy Malty, Wenming Duan, Terek Been, Javier Hernandez, Maria Mangos, Jocelyn Nurtanto, Mohan Babu, Liliana Attisano, Walid A. Houry, Theo J. Moraes, Alan Cochrane |
| 77 |
[GO] |
2023―Okt―30 |
Analysis of spike and accessory 3c genes mutations of less virulent and FIP-associated feline coronaviruses in Beijing, China |
Jingru Zhu, Shuqi Deng, Danxia Mou, Gege Zhang, Yingying Fu, Wei Huang, Yueping Zhang, Yanli lyu |
| 78 |
[GO] |
2023―Sep―29 |
RACK1 promotes porcine reproductive and respiratory syndrome virus infection in Marc-145 cells through ERK1/2 activation |
Xinxian Wang, Junlong Bi, Ying Yang, Lijun Li, Runting Zhang, Yongneng Li, Meiling Cheng, Wenying Li, Guishu Yang, Yingbo Lin, Jianping Liu, Gefen Yin |
| 79 |
[GO] |
2023―Sep―25 |
An engineered A549 cell line expressing CD13 and TMPRSS2 is permissive to clinical isolate of human coronavirus 229E |
Laurensius Kevin Lie, Aleksandra Synowiec, Jedrzej Mazur, Lukasz Rabalski, Krzysztof Pyrć |
| 80 |
[GO] |
2023―Sep―18 |
Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution |
Sultana Zahura Afrin, Fardousi Akter Sathi, Mohammed Nooruzzaman, Rokshana Parvin |
| 81 |
[GO] |
2023―Aug―26 |
Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023 |
Il-Hwan Kim, Jin Sun No, Jeong-Ah Kim, Ae Kyung Park, HyeokJin Lee, Jeong-Min Kim, Nam-Joo Lee, Chi-Kyeong Kim, Chae Young Lee, SangHee Woo, Jaehee Lee, JeeEun Rhee, Eun-Jin Kim |
| 82 |
[GO] |
2023―Aug―08 |
Molnupiravir, a ribonucleoside antiviral prodrug against SARS-CoV-2, alters the voltage-gated sodium current and causes adverse events |
Ai-Li Shiau, Kuan-Hsien Lee, Hsin-Yen Cho, Tzu-Hsien Chuang, Meng-Cheng Yu, Chao-Liang Wu, Sheng-Nan Wu |
| 83 |
[GO] |
2023―Aug―06 |
In silico screening of SARS-CoV2 helicase using African natural products: Docking and molecular dynamics approaches |
Hamada R. Knany, Sherif A. Elsabbagh, Moustafa A. Shehata, Wagdy M. Eldehna, Adnan A. Bekhit, Tamer M. Ibrahim |
| 84 |
[GO] |
2023―Jul―28 |
Physicochemical effects of emerging exchanges on the spike protein's RBM of the SARS-CoV-2 Omicron subvariants BA.1-BA.5 and its influence on the biological properties and attributes developed by these subvariants |
Robério Amorim de Almeida Pondé |
| 85 |
[GO] |
2023―Jul―24 |
Macro1 domain residue F156: A hallmark of SARS-cov-2 de-MARylation specificity |
Oney Ortega Granda, Karine Alvarez, Maria J. Mate-Perez, Bruno Canard, François Ferron, Nadia Rabah |
| 86 |
[GO] |
2023―Jul―24 |
Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo |
Yu Xiao, Ling Wang, Shi-song Fang, Fan Luo, Shu-liang Chen, Lin Ye, Wei Hou |
| 87 |
[GO] |
2023―Jul―05 |
SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro |
Kelsey Briggs, Ryan Sweeney, David S. Blehert, Erica Spackman, David L. Suarez, Darrell R. Kapczynski |
| 88 |
[GO] |
2023―Jun―15 |
A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2 |
Rina Su, Zhuangzhuang Shi, Entao Li, Menghan Zhu, Dongxu Li, Xiawei Liu, Yue Sun, Na Feng, Jianzhong Wang, Tiecheng Wang, Xianzhu Xia, Weiyang Sun, Yuwei Gao |
| 89 |
[GO] |
2023―Jun―05 |
Emergence of SARS-CoV-2 serotype(s): Is it a matter of time? |
José Valter Joaquim Silva Júnior, Ricardo Durães-Carvalho, Joelma Rodrigues de Souza, Luiz Mário Ramos Janini, Rudi Weiblen, Eduardo Furtado Flores |
| 90 |
[GO] |
2023―Apr―18 |
The 3′UTR region of the DNA repair gene PARP-1 May increase the severity of COVID-19 by altering the binding of antiviral miRNAs |
Büşra Yilmaz, Güneş Çakmak Genç, Sevim Karakaş Çelik, Nihal Pişkin, Emre Horuz, Ahmet DURSUN |
| 91 |
[GO] |
2023―Apr―18 |
Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature |
Thomas Pottage, Okechukwu Onianwa, Barry Atkinson, Antony Spencer, Allan M. Bennett |
| 92 |
[GO] |
2023―Apr―05 |
Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets |
Xiangjie Sun, Jessica A. Belser, Troy J. Kieran, Nicole Brock, Joanna A. Pulit-Penaloza, Claudia Pappas, Poulami Basu Thakur, Joyce Jones, David E. Wentworth, Bin Zhou, Terrence M. Tumpey, Taronna R. Maines |
| 93 |
[GO] |
2023―Mrz―16 |
Genomic characterization and molecular evolution of SARS-CoV-2 in Rio Grande do Sul State, Brazil |
Amanda de Menezes Mayer, Patrícia Aline Gröhs Ferrareze, Luiz Felipe Valter de Oliveira, Tatiana Schäffer Gregianini, Carla Lucia Andretta Moreira Neves, Gabriel Dickin Caldana, Lívia Kmetzsch, Claudia Elizabeth Thompson |
| 94 |
[GO] |
2023―Mrz―10 |
Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks |
Shubhangi Kandwal, Darren Fayne |
| 95 |
[GO] |
2023―Feb―22 |
HnRNP K reduces viral gene expression by targeting cytosine-rich sequences in porcine reproductive and respiratory syndrome virus-2 genome to dampen the viral growth |
Huiyuan Jing, Yuzhen Song, Huawei Li, Erzhen Duan, Jie Liu, Wenting Ke, Ran Tao, Yang Li, Pandeng Zhao, Jinhe Wang, Sufang Cao, Haihua Wang, Yanting Sun, Yan Zhang |
| 96 |
[GO] |
2023―Jan―14 |
Application of codon pair deoptimization for ORF7-induced attenuation of type I porcine reproductive and respiratory syndrome virus without reduced immune responses |
Sang-Ho Cha, Su-Hwa You, Min-A Lee, Jong-Hyuk Baek, Sun-Hee Cho, Jiwoon Jeong, Chang-Joo Park, Myung-Shin Lee, Changhoon Park |
| 97 |
[GO] |
2022―Dez―06 |
Long-term persistence of IgG antibodies in recovered COVID-19 individuals at 18 months post-infection and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response: Analysis using fixed-effects linear regression model |
Puya Dehgani-Mobaraki, Chao Wang, Alessandro Floridi, Emanuela Floridi, Sunny Dawoodi, Asiya K. Zaidi |
| 98 |
[GO] |
2022―Nov―28 |
Corrigendum to “A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination” [Virology 566 (2022) 56-59] |
Zhidong Hu, Jian-Ping Chen, Jin-Chuan Xu, Zhen-Yan Chen, Rong Qu, Ling Zhang, Wenrong Yao, Juan Wu, Heng Yang, Douglas B. Lowrie, Yong Liu, Xiao-Yong Fan |
| 99 |
[GO] |
2022―Nov―18 |
Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases |
Inês Figueiredo-Nunes, João Trigueiro-Louro, Helena Rebelo-de-Andrade |
| 100 |
[GO] |
2022―Okt―07 |
Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteins |
Ruchi Rani, Siwen Long, Akshay Pareek, Preeti Dhaka, Ankur Singh, Pravindra Kumar, Gerald McInerney, Shailly Tomar |
| 101 |
[GO] |
2022―Sep―30 |
SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season |
Cynthia Y. Tang, Maria Boftsi, Lindsay Staudt, Jane A. McElroy, Tao Li, Sabrina Duong, Adrienne Ohler, Detlef Ritter, Richard Hammer, Jun Hang, Xiu-Feng Wan |
| 102 |
[GO] |
2022―Sep―20 |
Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants |
Rui Wang, Xun Huang, Tianshu Cao, Chunyun Sun, Dan Luo, Hongying Qiu, Mei Wu, Xingyao Huang, Chulin Yu, Jing Li, Desheng Kong, Juan Ma, Xiao Zhang, Ping Hu, Yanjing Zhang, Chunxia Luo, Hui Zhao, Yuchang Li, Yongqiang Deng, Chengfeng Qin, Liangzhi Xie |
| 103 |
[GO] |
2022―Sep―19 |
Faecal virome of the Australian grey-headed flying fox from urban/suburban environments contains novel coronaviruses, retroviruses and sapoviruses |
Kate Van Brussel, Jackie E. Mahar, Ayda Susana Ortiz-Baez, Maura Carrai, Derek Spielman, Wayne S.J. Boardman, Michelle L. Baker, Julia A. Beatty, Jemma L. Geoghegan, Vanessa R. Barrs, Edward C. Holmes |
| 104 |
[GO] |
2022―Sep―07 |
Estimation of virus-mediated cell fusion rate of SARS-CoV-2 |
Ava Amidei, Hana M. Dobrovolny |
| 105 |
[GO] |
2022―Aug―27 |
Strain wars 4 - Darwinian evolution through Gibbs’ glasses: Gibbs energies of binding and growth explain evolution of SARS-CoV-2 from Hu-1 to BA.2 |
Marko Popovic |
| 106 |
[GO] |
2022―Aug―14 |
Transcriptomic analysis reveals crucial regulatory roles of immediate-early response genes and related signaling pathways in coronavirus infectious bronchitis virus infection |
Li Xia Yuan, Bei Yang, To Sing Fung, Rui Ai Chen, Ding Xiang Liu |
| 107 |
[GO] |
2022―Jul―31 |
Identification of CD163 regions that are required for porcine reproductive and respiratory syndrome virus (PRRSV) infection but not for binding to viral envelope glycoproteins |
Ana M.M. Stoian, Raymond R.R. Rowland, Alberto Brandariz-Nuñez |
| 108 |
[GO] |
2022―Jul―16 |
A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors |
Haohao Yan, Zhicheng Liu, Gangan Yan, Xiaoli Liu, Xiaoping Liu, Yanchang Wang, Yunyu Chen |
| 109 |
[GO] |
2022―Jun―16 |
Potential linear B-cells epitope change to a helix structure in the spike of Omicron 21L or BA.2 predicts increased SARS-CoV-2 antibodies evasion |
Walid Al-Zyoud, Hazem Haddad |
| 110 |
[GO] |
2022―Jun―15 |
In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing |
Ahmed Abdelkader, Amal A. Elzemrany, Mennatullah El-Nadi, Sherif A. Elsabbagh, Moustafa A. Shehata, Wagdy M. Eldehna, Mohamed El-Hadidi, Tamer M. Ibrahim |
| 111 |
[GO] |
2022―Jun―10 |
Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein |
Heeji Lim, Se Eun Kim, Yun Ha Lee, Yun-Ho Hwang, Su Hwan Kim, Mi Young Kim, Gyung Tae Chung, You-Jin Kim, Dokeun Kim, Jung-Ah Lee |
| 112 |
[GO] |
2022―Mai―16 |
Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection |
Prabhakaran Kumar, Manikannan Mathayan, Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vuk Koprivica, Gunther Birznieks, Mihael H. Polymeropoulos, Bellur S. Prabhakar |
| 113 |
[GO] |
2022―Mai―12 |
Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern |
R.A.A. Pondé |
| 114 |
[GO] |
2022―Mai―10 |
Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant |
Kanwal Khan, Salman Ali Khan, Khurshid Jalal, Zaheer Ul-Haq, Reaz Uddin |
| 115 |
[GO] |
2022―Apr―12 |
Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E |
Yue Zhu, Frank Scholle, Samantha C. Kisthardt, De-Yu Xie |
| 116 |
[GO] |
2022―Mrz―29 |
Strain wars 2: Binding constants, enthalpies, entropies, Gibbs energies and rates of binding of SARS-CoV-2 variants |
Marko Popovic |
| 117 |
[GO] |
2022―Mrz―22 |
Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease |
Mohamed K. El-Ashrey, Riham O. Bakr, Marwa A.A. Fayed, Rana H. Refaey, Yassin M. Nissan |
| 118 |
[GO] |
2022―Mrz―07 |
Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants |
Taotao Mi, Tiantian Wang, Huifang Xu, Peng Sun, Xuchen Hou, Xinwei Zhang, Qian Ke, Jiawen Liu, Shengwei Hu, Jun Wu, Bo Liu |
| 119 |
[GO] |
2022―Feb―18 |
The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 - Results from a prospective cohort of outpatient COVID-19 cases |
Kerstin Puchinger, Noemi Castelletti, Raquel Rubio-Acero, Christof Geldmacher, Tabea M. Eser, Flora Deák, Ivana Paunovic, Abhishek Bakuli, Elmar Saathoff, Alexander von Meyer, Alisa Markgraf, Philine Falk, Jakob Reich, Friedrich Riess, Philipp Girl, Katharina Müller, Katja Radon, Jessica Michelle Guggenbuehl Noller, Roman Wölfel, Michael Hoelscher, Inge Kroidl, Andreas Wieser, Laura Olbrich, Emad Alamoudi, Jared Anderson, Maximilian Baumann, Marieke Behlen, Jessica Beyerl, Rebecca Böhnlein, Anna Brauer, Vera Britz, Jan Bruger, Friedrich Caroli, Lorenzo Contento, Jana Diekmannshemke, Anna Do, Gerhard Dobler, Ute Eberle, Judith Eckstein, Jonathan Frese, Felix Forster, Turid Frahnow, Günter Fröschl, Otto Geisenberger, Kristina Gillig, Arlett Heiber, Christian Hinske, Janna Hoefflin, Tim Hofberger, Michael Höfinger, Larissa Hofmann, Sacha Horn, Kristina Huber, Christian Janke, Ursula Kappl, Charlotte Kiani, Arne Kroidl, Michael Laxy, Reiner Leidl, Felix Lindner, Rebecca Mayrhofer, Anna-Maria Mekota, Hannah Müller, Dafni Metaxa, Leonie Pattard, Michel Pletschette, Stephan Prückner, Konstantin Pusl, Elba Raimúndez, Camila Rothe, Nicole Schäfer, Paul Schandelmaier, Lara Schneider, Sophie Schultz, Mirjam Schunk, Lars Schwettmann, Heidi Seibold, Peter Sothmann, Paul Stapor, Fabian Theis, Verena Thiel, Sophie Thiesbrummel, Niklas Thur, Julia Waibel, Claudia Wallrauch, Simon Winter, Julia Wolff, Pia Wullinger, Houda Yaqine, Sabine Zange, Eleftheria Zeggini, Thomas Zimmermann, Anna Zielke, Mohamed Ibraheem, Mohamed Ahmed, Marc Becker, Paulina Diepers, Yannik Schälte, Mercè Garí, Peter Pütz, Michael Pritsch, Volker Fingerle, Ronan Le Gleut, Leonard Gilberg, Isabel Brand, Max Diefenbach, Tabea Eser, Franz Weinauer, Silke Martin, Ernst-Markus Quenzel, Jürgen Durner, Philipp Girl, Katharina Müller, Katja Radon, Christiane Fuchs, Jan Hasenauer |
| 120 |
[GO] |
2022―Feb―12 |
Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells |
Darrell R. Kapczynski, Ryan Sweeney, Erica Spackman, Mary Pantin-Jackwood, David L. Suarez |
| 121 |
[GO] |
2022―Feb―02 |
Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic |
Ezequiel G. Mogro, Daniela Bottero, Mauricio J. Lozano |
| 122 |
[GO] |
2022―Jan―17 |
SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway |
Huanzhou Xu, Ibukun A. Akinyemi, Siddhi A. Chitre, Julia C. Loeb, John A. Lednicky, Michael T. McIntosh, Sumita Bhaduri-McIntosh |
| 123 |
[GO] |
2021―Dez―14 |
Analysis of a crucial interaction between the coronavirus nucleocapsid protein and the major membrane-bound subunit of the viral replicase-transcriptase complex |
Cheri A. Koetzner, Kelley R. Hurst-Hess, Lili Kuo, Paul S. Masters |
| 124 |
[GO] |
2021―Dez―04 |
Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses |
Nadereh Naderi, Mahsa Rahimzadeh |
| 125 |
[GO] |
2021―Dez―01 |
A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination |
Zhidong Hu, Jian-Ping Chen, Jin-Chuan Xu, Zhen-Yan Chen, Rong Qu, Ling Zhang, Wenrong Yao, Juan Wu, Heng Yang, Douglas B. Lowrie, Yong Liu, Xiao-Yong Fan |
| 126 |
[GO] |
2021―Nov―27 |
Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro |
M.H. Raymonda, J.H. Ciesla, M. Monaghan, J. Leach, G. Asantewaa, L.A. Smorodintsev-Schiller, M.M. Lutz, X.L. Schafer, T. Takimoto, S. Dewhurst, J. Munger, I.S. Harris |
| 127 |
[GO] |
2021―Nov―27 |
Microsecond simulations and CD spectroscopy reveals the intrinsically disordered nature of SARS-CoV-2 spike-C-terminal cytoplasmic tail (residues 1242-1273) in isolation |
Prateek Kumar, Taniya Bhardwaj, Neha Garg, Rajanish Giri |
| 128 |
[GO] |
2021―Okt―30 |
Swine acute diarrhea syndrome coronavirus replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway |
Jiyu Zhang, Liaoyuan Zhang, Hongyan Shi, Shufeng Feng, Tingshuai Feng, Jianfei Chen, Xin Zhang, Yuru Han, Jianbo Liu, Yiming Wang, Zhaoyang Ji, Zhaoyang Jing, Dakai Liu, Da Shi, Li Feng |
| 129 |
[GO] |
2021―Okt―22 |
Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021 |
Sultana Zahura Afrin, Md Taohidul Islam, Shyamal Kumar Paul, Nobumichi Kobayashi, Rokshana Parvin |
| 130 |
[GO] |
2021―Okt―04 |
Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses |
Yining Wang, Pengfei Li, Kundan Solanki, Yang Li, Zhongren Ma, Maikel P. Peppelenbosch, Mirza S. Baig, Qiuwei Pan |
| 131 |
[GO] |
2021―Sep―11 |
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity |
Shang Yu Gong, Debashree Chatterjee, Jonathan Richard, Jérémie Prévost, Alexandra Tauzin, Romain Gasser, Yuxia Bo, Dani Vézina, Guillaume Goyette, Gabrielle Gendron-Lepage, Halima Medjahed, Michel Roger, Marceline Côté, Andrés Finzi |
| 132 |
[GO] |
2021―Sep―03 |
Adenovirus transduction to express human ACE2 causes obesity-specific morbidity in mice, impeding studies on the effect of host nutritional status on SARS-CoV-2 pathogenesis |
Pallavi Rai, Christina Chuong, Tanya LeRoith, James W. Smyth, Julia Panov, Moshe Levi, Kylene Kehn-Hall, Nisha K. Duggal, James-Weger Lucarelli |
| 133 |
[GO] |
2021―Aug―28 |
Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients |
Ahmed S. Abdelhafiz, Mariam A. Fouad, Mohamed M. Sayed-Ahmed, Mahmoud M. Kamel, Asmaa Ali, Merhan Fouda, Mahmoud A. Khalil, Ahmed S. Abdel-Moneim, Lamyaa M. Kamal |
| 134 |
[GO] |
2021―Jul―28 |
Prediction of two novel overlapping ORFs in the genome of SARS-CoV-2 |
Angelo Pavesi |
| 135 |
[GO] |
2021―Jul―23 |
SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung |
Lauren Byrd-Leotis, Yi Lasanajak, Thomas Bowen, Kelly Baker, Xuezheng Song, Mehul S. Suthar, Richard D. Cummings, David A. Steinhauer |
| 136 |
[GO] |
2021―Jun―28 |
Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants’ interaction with ACE2 to understand the binding affinity and stability |
Jyoti Verma, Naidu Subbarao |
| 137 |
[GO] |
2021―Jun―19 |
Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains |
Peyman Taghizadeh, Sadegh Salehi, Ali Heshmati, Seyed Massoud Houshmand, Kolsoum InanlooRahatloo, Forouzandeh Mahjoubi, Mohammad Hossein Sanati, Hadi Yari, Afagh Alavi, Saeid Amel Jamehdar, Soroosh Dabiri, Hamid Galehdari, Mohammad Reza Haghshenas, Amir Masoud Hashemian, Abtin Heidarzadeh, Issa Jahanzad, Elham Kheyrani, Ahmad Piroozmand, Ali Mojtahedi, Hadi Razavi Nikoo, Mohammad Masoud Rahimi Bidgoli, Nayebali Rezvani, Mehdi Sepehrnejad, Arash Shakibzadeh, Gholamreza Shariati, Noorossadat Seyyedi, Seyed MohammadSaleh Zahraei, Iman Safari, Elahe Elahi |
| 138 |
[GO] |
2021―Jun―18 |
Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia |
Mihkel Plaas, Kadri Seppa, Nayana Gaur, Priit Kasenõmm, Mario Plaas |
| 139 |
[GO] |
2021―Mai―25 |
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2 |
Shuai Ge, Jiayu Lu, Yajing Hou, Yuexin Lv, Cheng Wang, Huaizhen He |
| 140 |
[GO] |
2021―Mai―06 |
Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia |
Fatmah M.A. Naemi, Shurooq Al-adwani, Heba Al-khattabi, Ashwaq Al-nazawi |
| 141 |
[GO] |
2021―Apr―21 |
Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses |
Evelyn A. Kurt-Jones, Tim Dudek, Daisuke Watanabe, Leisa Mandell, Jenny Che, Shenghua Zhou, LuCheng Cao, Thomas Greenough, Gregory J. Babcock, Fernando Diaz, Hyung Suk Oh, Changhong Zhou, Robert W. Finberg, David M. Knipe |
| 142 |
[GO] |
2021―Mrz―19 |
The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein |
Xuemin Chen, Christina A. Rostad, Larry J. Anderson, He-ying Sun, Stacey A. Lapp, Kathy Stephens, Laila Hussaini, Theda Gibson, Nadine Rouphael, Evan J. Anderson |
| 143 |
[GO] |
2021―Mrz―18 |
Conflicting and ambiguous names of overlapping ORFs in SARS-CoV-2: A homology-based resolution |
Irwin Jungreis, Chase W. Nelson, Zachary Ardern, Yaara Finkel, Nevan J. Krogan, Kei Sato, John Ziebuhr, Noam Stern-Ginossar, Angelo Pavesi, Andrew E. Firth, Alexander E. Gorbalenya, Manolis Kellis |
| 144 |
[GO] |
2021―Mrz―05 |
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India |
Kaustuv Nayak, Kamalvishnu Gottimukkala, Sanjeev Kumar, Elluri Seetharami Reddy, Venkata Viswanadh Edara, Robert Kauffman, Katharine Floyd, Grace Mantus, Deepali Savargaonkar, Pawan Kumar Goel, Satyam Arora, Manju Rahi, Carl W. Davis, Susanne Linderman, Jens Wrammert, Mehul S. Suthar, Rafi Ahmed, Amit Sharma, Kaja Murali-Krishna, Anmol Chandele |
| 145 |
[GO] |
2021―Feb―26 |
On the road to ending the COVID-19 pandemic: Are we there yet? |
James Brett Case, Emma S. Winkler, John M. Errico, Michael S. Diamond |
| 146 |
[GO] |
2021―Feb―22 |
Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines |
Ahmed S. Abdel-Moneim, Elsayed M. Abdelwhab, Ziad A. Memish |
| 147 |
[GO] |
2021―Feb―22 |
Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis |
Naoki Nomura, Keita Matsuno, Masashi Shingai, Marumi Ohno, Toshiki Sekiya, Ryosuke Omori, Yoshihiro Sakoda, Robert G. Webster, Hiroshi Kida |
| 148 |
[GO] |
2021―Feb―09 |
Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2 |
Teodora Djukic, Maja Mladenovic, Dragana Stanic-Vucinic, Jelena Radosavljevic, Katarina Smiljanic, Ljiljana Sabljic, Marija Devic, Danica Cujic, Tamara Vasovic, Ana Simovic, Mirjana Radomirovic, Tanja Cirkovic Velickovic |
| 149 |
[GO] |
2021―Feb―04 |
Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion |
Samiran Mondal, Abhijit Karmakar, Tamanna Mallick, Naznin Ara Begum |
| 150 |
[GO] |
2021―Feb―01 |
Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody |
James S. Terry, Loran BR. Anderson, Michael S. Scherman, Carley E. McAlister, Rushika Perera, Tony Schountz, Brian J. Geiss |
| 151 |
[GO] |
2021―Jan―26 |
Detecting SARS-CoV-2 3CLpro expression and activity using a polyclonal antiserum and a luciferase-based biosensor |
Amornrat O'Brien, Da-Yuan Chen, Matthew Hackbart, Brianna J. Close, Timothy E. O'Brien, Mohsan Saeed, Susan C. Baker |
| 152 |
[GO] |
2021―Jan―25 |
The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters |
Charles B. Stauft, Christopher Z. Lien, Prabhuanand Selvaraj, Shufeng Liu, Tony T. Wang |
| 153 |
[GO] |
2021―Jan―13 |
A novel ratio of CD8+:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome |
Maria G. Detsika, Kleio Ampelakiotou, Eirini Grigoriou, Katherina Psarra, Edison Jahaj, Charis Roussos, Ioanna Dimopoulou, Stylianos E. Orfanos, Alexandra Tsirogianni, Anastasia Kotanidou |
| 154 |
[GO] |
2021―Jan―08 |
Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution |
Jeremy Ratcliff, Peter Simmonds |
| 155 |
[GO] |
2021―Jan―07 |
Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan |
Masaru Takeshita, Naoshi Nishina, Saya Moriyama, Yoshimasa Takahashi, Yoshifumi Uwamino, Mika Nagata, Wataru Aoki, Katsunori Masaki, Makoto Ishii, Hideyuki Saya, Yasushi Kondo, Yuko Kaneko, Katsuya Suzuki, Koichi Fukunaga, Tsutomu Takeuchi |
| 156 |
[GO] |
2021―Jan―07 |
Corrigendum to “Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis” [Virology volume (2021) 154-156] |
Byron Freire-Paspuel, Patricio Vega-Marino, Alberto Velez, Marilyn Cruz, Franklin Perez, Miguel Angel Garcia-Bereguiain |
| 157 |
[GO] |
2020―Dez―30 |
Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs |
Shweta A. More, Akshay S. Patil, Nikhil S. Sakle, Santosh N. Mokale |
| 158 |
[GO] |
2020―Dez―29 |
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques |
Hirohito Ishigaki, Misako Nakayama, Yoshinori Kitagawa, Cong Thanh Nguyen, Kaori Hayashi, Masanori Shiohara, Bin Gotoh, Yasushi Itoh |
| 159 |
[GO] |
2020―Dez―25 |
Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target |
Jamie A. Kelly, Michael T. Woodside, Jonathan D. Dinman |
| 160 |
[GO] |
2020―Dez―24 |
Coronavirus infection induces progressive restructuring of the endoplasmic reticulum involving the formation and degradation of double membrane vesicles |
Elaine M. Mihelc, Susan C. Baker, Jason K. Lanman |
| 161 |
[GO] |
2020―Dez―24 |
Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study |
Rana H. Refaey, Mohamed K. El-Ashrey, Yassin M. Nissan |
| 162 |
[GO] |
2020―Dez―16 |
Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2 |
Yongjing Zhang, Jue Wang, Shiling Hu, Zhuoyin Xue, Cheng Wang, Nan Wang |
| 163 |
[GO] |
2020―Nov―28 |
Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection |
Rentao Yu, Shun Tan, Yunjie Dan, Yanqiu Lu, Juan Zhang, Zhaoxia Tan, Xiaoqing He, Xiaomei Xiang, Yi Zhou, Yanzhi Guo, Guohong Deng, Yaokai Chen, Wenting Tan |
| 164 |
[GO] |
2020―Nov―18 |
Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis. |
Byron Freire-Paspuel, Patricio Vega-Mariño, Alberto Velez, Marilyn Cruz, Franklin Perez, Miguel Angel Garcia-Bereguiain |
| 165 |
[GO] |
2020―Okt―31 |
Immunization with a recombinant fusion of porcine reproductive and respiratory syndrome virus modified GP5 and ferritin elicits enhanced protective immunity in pigs |
Hui Ma, Xiangmin Li, Jianglong Li, Zekai Zhao, Huawei Zhang, Genxi Hao, Huanchun Chen, Ping Qian |
| 166 |
[GO] |
2020―Okt―28 |
A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2 |
Rajarshi Bhattacharya, Aayatti Mallick Gupta, Suranjita Mitra, Sukhendu Mandal, Swadesh R. Biswas |
| 167 |
[GO] |
2020―Sep―28 |
Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients |
Linghua Li, Yuanhao Liang, Fengyu Hu, Huanchang Yan, Yueping Li, Zhiwei Xie, Liping Huang, Jianhui Zhao, Zhengwei Wan, Haiying Wang, Jingwei Shui, Weiping Cai, Shixing Tang |
| 168 |
[GO] |
2020―Sep―24 |
The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies |
Elahe Seyed Hosseini, Narjes Riahi Kashani, Hossein Nikzad, Javid Azadbakht, Hassan Hassani Bafrani, Hamed Haddad Kashani |
| 169 |
[GO] |
2020―Aug―26 |
Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity |
Leandro R. Jones, Julieta M. Manrique |
| 170 |
[GO] |
2020―Aug―23 |
Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2 |
Hana M. Dobrovolny |
| 171 |
[GO] |
2020―Aug―20 |
Replicase 1a gene plays a critical role in pathogenesis of avian coronavirus infectious bronchitis virus |
Jing Zhao, Keran Zhang, Jinlong Cheng, Wenfeng Jia, Ye Zhao, Guozhong Zhang |
| 172 |
[GO] |
2020―Jul―29 |
A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) |
Tao Wu, Yiyue Ge, Kangchen Zhao, Xiaojuan Zhu, Yin Chen, Bin Wu, Fengcai Zhu, Baoli Zhu, Lunbiao Cui |
| 173 |
[GO] |
2020―Jun―13 |
Growth, detection, quantification, and inactivation of SARS-CoV-2 |
James Brett Case, Adam L. Bailey, Arthur S. Kim, Rita E. Chen, Michael S. Diamond |
| 174 |
[GO] |
2020―Mai―25 |
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series |
Negar Mohtadi, Abas Ghaysouri, Samira Shirazi, Elham Shafiee, Elham Bastani, Taleb Kokhazadeh, Hamed Tavan |
| 175 |
[GO] |
2020―Mai―19 |
The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells |
Hussin A. Rothan, Shannon Stone, Janhavi Natekar, Pratima Kumari, Komal Arora, Mukesh Kumar |
| 176 |
[GO] |
2020―Apr―30 |
Association of viral load with serum biomakers among COVID-19 cases |
Fengjuan Shi, Tao Wu, Xiaojuan Zhu, Yiyue Ge, Xiaoyan Zeng, Ying Chi, Xuefei Du, Liguo Zhu, Fengcai Zhu, Baoli Zhu, Lunbiao Cui, Bin Wu |
| 177 |
[GO] |
2020―Feb―04 |
Hyper-phosphorylation of nsp2-related proteins of porcine reproductive and respiratory syndrome virus |
Pengcheng Shang, Fangfeng Yuan, Saurav Misra, Yanhua Li, Ying Fang |
|
